Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients (ASCIT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Universitaire Ziekenhuizen Leuven.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Kathleen Claes, Universitaire Ziekenhuizen Leuven Identifier:
First received: October 18, 2007
Last updated: October 5, 2011
Last verified: October 2011

The purpose of this study is to determine the:

  • Natural history of calcification posttransplantation
  • Natural history of BMC following renal transplantation
  • Reverse correlation between calcification score and aortic calcifications following renal transplantation
  • Correlation of IMT, BMC, PWV and biochemical variables
  • Correlation of IMT, BMC, PWV, biochemical variables and outcome
  • Predictors of CV disease after transplantation
  • Predictors of IMT progression, BMC loss and PWV progression after renal transplantation

Condition Intervention
Renal Transplant
Arterial Stiffness
Other: no intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients

Resource links provided by NLM:

Further study details as provided by Universitaire Ziekenhuizen Leuven:

Primary Outcome Measures:
  • cardiovascular outcome [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

serum, plasma, urine

Estimated Enrollment: 100
Study Start Date: October 2006
Estimated Study Completion Date: October 2013
Groups/Cohorts Assigned Interventions
incident renal transplant patients
Other: no intervention
no intervention


Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

incident renal transplant recipients


Inclusion Criteria:

  • Incident renal transplant patients or combined renal/pancreas transplant patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00547040

Contact: kathleen Claes, MD 0032/16344580

UZ Gasthuisberg Recruiting
Leuven, Belgium, 3000
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Principal Investigator: kathleen Claes, MD UZ Leuven
Principal Investigator: kathleen claes, md UZ Leuven
  More Information

No publications provided

Responsible Party: Kathleen Claes, md, Universitaire Ziekenhuizen Leuven Identifier: NCT00547040     History of Changes
Other Study ID Numbers: ML3775
Study First Received: October 18, 2007
Last Updated: October 5, 2011
Health Authority: Belgium: Institutional Review Board

Keywords provided by Universitaire Ziekenhuizen Leuven:
bone lesions

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Calcium Metabolism Disorders
Cardiovascular Diseases
Metabolic Diseases
Vascular Diseases processed this record on November 25, 2014